Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Reschke

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Cancers|July 2, 2021
Identifying High-Risk Tumors within AJCC Stage IB-III Melanomas Using a Seven-Marker Immunohistochemical SignatureRobin Reschke, Philipp Gussek, Mirjana Ziemer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 23, 2019
Reinduktion zielgerichteter Therapie beim metastasierten MelanomRobin Reschke, Jan-Christoph Simon, Mirjana Ziemer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 14, 2019
Rechallenge of targeted therapy in metastatic melanomaRobin Reschke, Jan-Christoph Simon, Mirjana Ziemer
International Journal of Molecular Sciences|June 27, 2024
Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic TargetsRobin Reschke, Alexander H Enk, Jessica C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 27, 2019
Anhaltende Remission eines metastasierten Melanoms unter zielgerichteter Therapie und Rituximab bei rheumatoider ArthritisRobin Reschke, Johannes Kohlmann, Christoph Baerwald, et al.
Pharmaceutics|August 29, 2024
T Cell-Engaging Bispecific Antibodies Targeting gp100 and PRAME: Expanding Application from Uveal Melanoma to Cutaneous MelanomaRobin Reschke, Alexander H Enk, Jessica C Hassel
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 12, 2019
[Rare form of a segmental neurofibromatosis with giant plexiform neurofibroma]Robin Reschke, Marketa Kadlecova, Sonja Grunewald, et al.
American Journal of Clinical Dermatology|December 20, 2024
Prognostic Biomarkers in Evolving Melanoma ImmunotherapyRobin Reschke, Alexander H Enk, Jessica C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 5, 2019
Sustained complete remission of metastatic melanoma on targeted therapy and rituximab for rheumatoid arthritisRobin Reschke, Johannes Kohlmann, Christoph Baerwald, et al.
Signal Transduction and Targeted Therapy|April 10, 2025
Adiponectin to the rescue: extracorporeal photopheresis for managing immune checkpoint inhibitor-induced toxicitiesRobin Reschke, Alexander H Enk, Jessica C Hassel
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Cancers|July 2, 2021
Identifying High-Risk Tumors within AJCC Stage IB-III Melanomas Using a Seven-Marker Immunohistochemical SignatureRobin Reschke, Philipp Gussek, Mirjana Ziemer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 23, 2019
Reinduktion zielgerichteter Therapie beim metastasierten MelanomRobin Reschke, Jan-Christoph Simon, Mirjana Ziemer
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 14, 2019
Rechallenge of targeted therapy in metastatic melanomaRobin Reschke, Jan-Christoph Simon, Mirjana Ziemer
International Journal of Molecular Sciences|June 27, 2024
Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic TargetsRobin Reschke, Alexander H Enk, Jessica C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 27, 2019
Anhaltende Remission eines metastasierten Melanoms unter zielgerichteter Therapie und Rituximab bei rheumatoider ArthritisRobin Reschke, Johannes Kohlmann, Christoph Baerwald, et al.
Pharmaceutics|August 29, 2024
T Cell-Engaging Bispecific Antibodies Targeting gp100 and PRAME: Expanding Application from Uveal Melanoma to Cutaneous MelanomaRobin Reschke, Alexander H Enk, Jessica C Hassel
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|May 12, 2019
[Rare form of a segmental neurofibromatosis with giant plexiform neurofibroma]Robin Reschke, Marketa Kadlecova, Sonja Grunewald, et al.
American Journal of Clinical Dermatology|December 20, 2024
Prognostic Biomarkers in Evolving Melanoma ImmunotherapyRobin Reschke, Alexander H Enk, Jessica C Hassel
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 5, 2019
Sustained complete remission of metastatic melanoma on targeted therapy and rituximab for rheumatoid arthritisRobin Reschke, Johannes Kohlmann, Christoph Baerwald, et al.
Signal Transduction and Targeted Therapy|April 10, 2025
Adiponectin to the rescue: extracorporeal photopheresis for managing immune checkpoint inhibitor-induced toxicitiesRobin Reschke, Alexander H Enk, Jessica C Hassel
Pageof 5